Ligand validation:3R4X

PZA: PYRAZINE-2-CARBOXAMIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3R4X_PZA_A_619	4%	41%	0.264	0.627	0.4	1.87	-	3	6	0	100%	0.7
3R4X_PZA_A_618	2%	37%	0.309	0.565	0.54	1.9	-	5	14	0	100%	1
3R55_PZA_A_620	6%	42%	0.241	0.672	0.47	1.75	-	3	6	0	100%	0.7
5FPD_PZA_B_1385	70%	79%	0.124	0.943	0.14	0.7	-	-	0	0	100%	0.88
8H0O_PZA_A_607	52%	2%	0.192	0.95	4.26	2.67	5	2	1	0	100%	1
7H8M_PZA_C_207	7%	88%	0.165	0.611	0.23	0.43	-	-	0	0	100%	0.66
5RTM_PZA_A_201	0%	11%	0.471	0.38	2.43	1.73	2	3	1	0	100%	0.52

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.